Sonoma Pharmaceuticals (SNOA) EPS (Basic) (2019 - 2022)
Sonoma Pharmaceuticals (SNOA) has 3 years of EPS (Basic) data on record, last reported at -$0.05 in Q4 2012.
- For Q4 2012, EPS (Basic) rose 44.44% year-over-year to -$0.05; the TTM value through Dec 2012 reached -$0.18, up 33.33%, while the annual FY2012 figure was -$0.27, 10.0% up from the prior year.
- EPS (Basic) reached -$0.05 in Q4 2012 per SNOA's latest filing, roughly flat from -$0.05 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.02 in Q2 2012 and bottomed at -$0.09 in Q2 2010.
- Average EPS (Basic) over 3 years is -$0.06, with a median of -$0.06 recorded in 2012.
- The widest YoY moves for EPS (Basic): up 75.0% in 2012, down 66.67% in 2012.
- A 3-year view of EPS (Basic) shows it stood at -$0.08 in 2010, then decreased by 12.5% to -$0.09 in 2011, then skyrocketed by 44.44% to -$0.05 in 2012.
- Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.05 in Q4 2012, -$0.05 in Q3 2012, and -$0.02 in Q2 2012.